# Discovery of novel circular RNAs of the apoptosis-related BAX gene in breast cancer, by combining nanopore and next-generation sequencing

**Authors:** Katerina Katsaraki, Giannis Vatsellas, Christos K. Kontos

PMC · DOI: 10.1007/s00438-026-02388-1 · Molecular Genetics and Genomics · 2026-03-17

## TL;DR

The study identifies new circular RNAs from the BAX gene in breast cancer, which may regulate cancer signaling and apoptosis.

## Contribution

The discovery of 82 novel BAX-derived circRNAs and their potential regulatory roles in breast cancer signaling is a key novelty.

## Key findings

- 106 BAX-derived circRNAs were identified, with 82 being novel and exhibiting diverse biogenesis features.
- Several circRNAs showed subtype-specific expression patterns in breast cancer cell lines.
- Some circRNAs may act as miRNA sponges and bind RNA-binding proteins, influencing apoptosis and cancer signaling pathways.

## Abstract

Circular RNAs (circRNAs) have emerged as significant regulators of cancer biology. However, the characterization and the regulatory potential of circRNAs deriving from key apoptotic genes remain poorly understood in breast cancer. We aimed to comprehensively characterize circRNAs originating from the pro-apoptotic BAX gene and predict their regulatory potential in BC signaling. Targeted amplification of circular BAX transcripts was conducted in eleven cancerous and one non-cancerous breast cell lines, followed by third-generation (nanopore) and next-generation sequencing. Finally, extensive bioinformatic analysis was conducted. Therefore, we identified 106 circRNAs, 82 of which were novel. These circRNAs exhibited diverse biogenesis features, including exon skipping, intron retention, and rare inclusion of exon 5. Expression profiling revealed subtype-specific patterns, with several circRNAs being detected only in triple-negative or luminal BC subtypes, while circ-BAX-55b was detected exclusively in the non-cancerous cell line. Many circRNAs were predicted to sponge miRNAs such as miR-152-5p, miR-4802-5p, and miR-3619-5p, potentially modulating signaling pathways including MAPK, PI3K/AKT, and NFκB. Extensive sponging of miR-152-5p, which targets BAX mRNA, suggests a feedback mechanism modulating apoptosis. Several circRNAs also contain binding sites for RNA-binding proteins (RBPs) such as RBM6 and HNRNPF, possibly dictating RNA fate. Overlapping miRNA and RBP-binding sites imply complex competitive or cooperative interactions. Additionally, multiple circRNAs, such as circ-BAX-6c, displayed translation-related features. In conclusion, these findings reveal a novel repertoire of BAX circRNAs with putative roles in BC signaling and apoptosis regulation. Moreover, they constitute a valuable resource for functional studies as well as potential biomarkers or therapeutic targets in breastcancer.

The online version contains supplementary material available at 10.1007/s00438-026-02388-1.

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581]
- **Proteins:** RBM6 (RNA binding motif protein 6), HNRNPF (heterogeneous nuclear ribonucleoprotein F)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, YBX2 (Y-box binding protein 2) [NCBI Gene 51087] {aka CONTRIN, CSDA3, DBPC, MSY2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HNRNPF (heterogeneous nuclear ribonucleoprotein F) [NCBI Gene 3185] {aka HNRPF, OK/SW-cl.23, mcs94-1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, MIR3619 (microRNA 3619) [NCBI Gene 100500828], MIR2113 (microRNA 2113) [NCBI Gene 100302164] {aka hsa-mir-2113}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, RBM6 (RNA binding motif protein 6) [NCBI Gene 10180] {aka 3G2, DEF-3, DEF3, HLC-11, NY-LU-12, g16}, MIR6513 (microRNA 6513) [NCBI Gene 102465256] {aka hsa-mir-6513, mir-6513}, MIR491 (microRNA 491) [NCBI Gene 574444] {aka MIRN491, hsa-mir-491, mir-491}, SUGP1 (SURP and G-patch domain containing 1) [NCBI Gene 57794] {aka F23858, RBP, SF4}, MIR4802 (microRNA 4802) [NCBI Gene 100616274], MIR152 (microRNA 152) [NCBI Gene 406943] {aka MIRN152, mir-152}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NOVA1 (NOVA alternative splicing regulator 1) [NCBI Gene 4857] {aka Nova-1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, ZNF638 (zinc finger protein 638) [NCBI Gene 27332] {aka NP220, ZFML, Zfp638}
- **Diseases:** BC (MESH:D001943), ASDT (MESH:D005547), hematological malignancies (MESH:D019337), inflammation (MESH:D007249), cancer (MESH:D009369)
- **Chemicals:** CO2 (MESH:D002245), N6-methyladenosine (MESH:C010223), TRI Reagent (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** NM_001291428 — Bos taurus (Bovine), Finite cell line (CVCL_3074), BT-474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179), T-47D — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0553), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), Hs 578T — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0332), MDA-MB-453 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0418), ZR-75-1 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0588), BT-20 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0178), MDA-MB-468 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0419), HCC70 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1270), MCF-12A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_3744), SK-BR-3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12995990/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12995990/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12995990/full.md

---
Source: https://tomesphere.com/paper/PMC12995990